Mesenchymal Stem Cell Culture by Size Selection and Hypoxia

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for culturing mesenchymal stem cells face challenges such as heterogeneous cell populations, decreased proliferative capacity, and rapid aging, making them difficult to develop as therapeutic agents, and existing methods are not suitable for good manufacturing process (GMP) applications.

Innovation Solution

A method involving the isolation of mesenchymal stem cells with a size of 8 μm or less and culturing them in a medium with specific concentrations of calcium and magnesium under hypoxic conditions (2-5% oxygen) to enhance proliferative capacity and differentiation potential.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional methods are used to culture mesenchymal stem cells, then cell quantity can be increased through passages, but the cells become heterogeneous and lose proliferative capacity

Engineering Contradiction:

Improvecell quantityVSAvoidcell homogeneity and proliferative capacity

Core Design Contradiction:

Quantity of substanceVSReliability

Solution Approach 1:

The patent segments the heterogeneous cell population by size using filtration (8 μm pore size) to isolate small mesenchymal stem cells from larger differentiated cells, maintaining population homogeneity while enabling expansion

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent changes the oxygen concentration parameter from conventional 21% to hypoxic conditions (2-5% oxygen), which maintains cell proliferative capacity and prevents differentiation during culture passages

Inventive Principle:

Principle #35Parameter changes

2Productivity

If mesenchymal stem cells are cultured under conventional conditions, then cell population can expand, but aging progresses rapidly and proliferative capacity decreases

Engineering Contradiction:

Improvecell expansionVSAvoidcell proliferative lifespan

Core Design Contradiction:

ProductivityVSDuration of action of moving object

Solution Approach 1:

The patent applies hypoxic conditions (2-5% oxygen) during culture, which extends the proliferative lifespan of mesenchymal stem cells and delays senescence, allowing sustained expansion without rapid aging

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent performs size-based filtration before culture to remove larger, aging cells in advance, ensuring the culture starts with a homogeneous population of young, proliferative cells

Inventive Principle:

Principle #10Preliminary action

3Quantity of substance

If standard culture methods are used, then cell quantity increases, but the equipment and process are not suitable for GMP manufacturing

Engineering Contradiction:

Improvecell quantityVSAvoidGMP compatibility

Core Design Contradiction:

Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent extracts the small mesenchymal stem cells from the heterogeneous population using simple filtration, creating a streamlined process that is easier to implement under GMP conditions compared to complex conventional culture methods

Inventive Principle:

Principle #2Taking out (Extraction)

Data Source

PatentUS10150950B2Method for culturing mesenchymal stem cells according to cell size

Publication Date: 2018.12.11 MEDIPOST

AI summary

A method for culturing mesenchymal stem cells. The method includes isolating mesenchymal stem cells having a size of 8 μm or less and culturing the mesenchymal stem cells in a medium containing calcium and magnesium and under a low oxygen condition. The method can significantly improve the proliferative capacity and differentiation potential of the mesenchymal stem cells.